| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/12/2008 | US7410993 3,6-disubstituted azabicyclo [3.1.0] hexane deriviatives useful as muscarinic receptor antagonists |
| 08/12/2008 | US7410992 Ophthalmic compositions for treating ocular hypertension |
| 08/12/2008 | US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors |
| 08/12/2008 | US7410990 Heterocyclic compounds |
| 08/12/2008 | US7410989 intravenous or oral administration of viricides against the Flaviviridae family of viruses; e.g. 2-[5(6)-Amidino-2-benzimidazoyl]-5-(4-nitrophenyl)furan |
| 08/12/2008 | US7410988 2-Amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 08/12/2008 | US7410987 Treating pruritus or pain, particularly that caused by a rheumatic disease, by administering a 2-[o-(aminoalkoxy)phenyl])-3-acylbenzothiazoline, e.g., 3-Acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)-propoxy)-5-methoxyphenyl]benzothiazoline |
| 08/12/2008 | US7410986 For therapy of inflammatory symptoms; tumors, ischemia and tumor |
| 08/12/2008 | US7410985 Useful for the chelation of ferric (III) ions for the removal of iron in chemical and biological systems; thalassaemia, sickle cell disease haemochromatosis; 1-Cyclopropyl-3-hydroxy-6-methyl-N-(3-methylbutyl)4-oxo-1,4-dihydropyridine-2-carboxamide |
| 08/12/2008 | US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis |
| 08/12/2008 | US7410983 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 08/12/2008 | US7410982 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride |
| 08/12/2008 | US7410981 low toxicity; 2-[methyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimida zol-1-yl]carbonyl]amino]ethyl acetate; superior antiulcer activity, a gastric acid secretion inhibitory action, a mucosa-protecting action, an antiHelicobacter pylori action |
| 08/12/2008 | US7410980 Performing crystallization by using an organic solvent selected from a ketone solvent, a nitrile solvent, and a mixture thereof, or a mixture of organic solvent and water; acetone or acetonitrile can be preferably used as the organic solvent |
| 08/12/2008 | US7410979 Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections |
| 08/12/2008 | US7410978 Once daily dosage forms of trospium |
| 08/12/2008 | US7410977 Fluorinated 4-azasteroids as androgen receptor modulators |
| 08/12/2008 | US7410976 acetyl coenzyme A carboxylase inhibitors; to treat various vascular, nervous system, metabolic, genital, digestive system, respiratory, neoplasm and infectious diseases; herbicides; N-{1'-[(4-methoxyquinolin-2-yl)carbonyl]-4-oxospiro[chroman-2,4'-piperidin]-6-yl}acetamide |
| 08/12/2008 | US7410975 Small molecule toll-like receptor (TLR) antagonists |
| 08/12/2008 | US7410974 Halogenated Quinazolinyl nitrofurans as antibacterial agents |
| 08/12/2008 | US7410973 4-amino-substituted pyrimidine derivatives |
| 08/12/2008 | US7410972 Compounds |
| 08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |
| 08/12/2008 | US7410970 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/12/2008 | US7410969 Antitumoral analogs of ET-743 |
| 08/12/2008 | US7410968 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 08/12/2008 | US7410967 For combating phytopathogenic diseases on plants and harvested food crops; pyrido(2,3-B)pyrazine derivatives; volatile enough to be active in the vapour phase |
| 08/12/2008 | US7410966 Use of and some novel imidazopyridines |
| 08/12/2008 | US7410965 In a matrix-forming, hydrophilic or hydrophobic polymer comprising a cellulose ether or ester of hydroxypropyl methyl cellulose, hydroxyethycellulose, hydroxypropycellulos, methycellulose, ethycellulose and/or carboxymethyl cellulose |
| 08/12/2008 | US7410964 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 08/12/2008 | US7410963 Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof |
| 08/12/2008 | US7410961 2,6-disubstituted piperiddines as modulators |
| 08/12/2008 | US7410960 Metal complexes and therapeutic uses thereof |
| 08/12/2008 | US7410959 To treat obesity or diabetes; reduction of serum cholesterol and the treatment of atherosclerosis |
| 08/12/2008 | US7410958 3 beta -1-(N',N'-dimethylaminopyridinium)-N-acetyloxy-19 beta ,28-epoxy-18 alpha -oleanan chloride; Plant fungicides and bactericides; antibiotic resistant staphylococcus and enterococcus; turf grasses; improved chemical resistance and stability |
| 08/12/2008 | US7410957 Method of treatment using bisphosphonic acid |
| 08/12/2008 | US7410956 Caspase inhibitor prodrugs |
| 08/12/2008 | US7410955 Therapeutic use of agonist ligands specific to G2A receptor |
| 08/12/2008 | US7410953 Anticancer agent |
| 08/12/2008 | US7410952 3'-(N,N-didemethyl)-3'-N-formylazithromycin or addition salt; used in a mixture with any azithromycin base or salt in any crystalline, polymorphic or amorphous form; formylation of 3'-aminoazithromycin carried out using acetic formic anhydride; bactericides; antibiotics |
| 08/12/2008 | US7410799 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 08/12/2008 | US7410759 Compositions and methods for diagnosing and treating mood disorders |
| 08/12/2008 | US7410663 Fatty acid glycerides; dietetics |
| 08/12/2008 | US7410659 Therapy of peripheral neuropathy using antioxidant flavonoids; reduced side effects |
| 08/12/2008 | US7410656 Isolated euphorbia plant compounds and derivatives; jatrophanes, pepluanes, paralianes, ingenanes; cytotoxicity against malignant melanomas and squamous cell carcinomas |
| 08/12/2008 | US7410655 comprises Potassium tetrachloroplatinate and lignohumic acid ammonium salts; nontoxic |
| 08/12/2008 | US7410652 Controlled release and taste masking oral pharmaceutical composition |
| 08/12/2008 | US7410651 Controlled release and taste masking oral pharmaceutical composition |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |
| 08/12/2008 | US7410635 Aerosol formulations and aerosol delivery of scopolamine |
| 08/12/2008 | CA2562918C Process for glucan preparation and therapeutic uses of glucan |
| 08/12/2008 | CA2547866C Farnesyl dibenzodiazepinone formulation |
| 08/12/2008 | CA2487331C Anti-inflammatory compositions and methods of use |
| 08/12/2008 | CA2432037C Famotidine injection solution |
| 08/12/2008 | CA2420461C Preparations for oral administration |
| 08/12/2008 | CA2408887C Medical composition kit for treating lesioned abnormal tissue |
| 08/12/2008 | CA2398111C 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/12/2008 | CA2396156C Osmotic device containing venlafaxine and an anti-psychotic agent |
| 08/12/2008 | CA2368675C Agent for prophylaxis and treatment of interstitial pneumonia and pulmonary fibrosis |
| 08/12/2008 | CA2368574C Compositions for preventing and treating type i allergy |
| 08/12/2008 | CA2359819C 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 08/12/2008 | CA2350786C Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 08/12/2008 | CA2326048C Peroral active agent suspension |
| 08/12/2008 | CA2320224C Method for modulating macrophage activation |
| 08/12/2008 | CA2315721C Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 08/12/2008 | CA2308660C Stable aqueous pharmaceutical composition comprising tezosentan |
| 08/12/2008 | CA2304568C Olanzapine pamoate formulations |
| 08/12/2008 | CA2257810C Skin wash composition comprising an .alpha.-hydroxy acid or other acid and a detergent base |
| 08/12/2008 | CA2256582C Oxa acids and related compounds for treating skin conditions |
| 08/12/2008 | CA2239799C Murine monoclonal anti-idiotype antibody 11d10 and methods of use thereof |
| 08/12/2008 | CA2238271C Pharmaceutical compositions comprising flurbiprofen |
| 08/12/2008 | CA2217590C Use of imidazo[1,2-a]pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia |
| 08/12/2008 | CA2217551C Photoactivated hypericin and the use thereof |
| 08/12/2008 | CA2188228C Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders |
| 08/12/2008 | CA2184828C Composition for inactivating irritants in fluids |
| 08/09/2008 | CA2618099A1 Antagonists of a non-selective cation channel in neural cells |
| 08/08/2008 | CA2619157A1 Anti-human papillomas virus composition |
| 08/07/2008 | WO2008095189A1 Methods and compositions for treating dyslipidaemia |
| 08/07/2008 | WO2008095186A1 Drug substance preparations, pharmaceutical compositions and dosage forms |
| 08/07/2008 | WO2008095142A1 Extended release pharmaceutical formulations of s-adenosylmethionine |
| 08/07/2008 | WO2008095093A2 Method of increasing cellular function and health of glutathione deficient animals |
| 08/07/2008 | WO2008095058A1 Hcv protease inhibitors |
| 08/07/2008 | WO2008094976A2 Use of estrogen receptor beta selective ligands for treating acute lung injuries |
| 08/07/2008 | WO2008094969A2 Combination therapy with angiogenesis inhibitors |
| 08/07/2008 | WO2008094959A1 Pharmaceutical composition comprising a campothecin derivative |
| 08/07/2008 | WO2008094958A1 Thiophene derivatives useful as medicaments for treating ocular hypertension |
| 08/07/2008 | WO2008094939A1 Use of chromium histidinate for treatment of cardiometabolic disorders |
| 08/07/2008 | WO2008094922A1 Photolabile dinitroindolinyl based compounds |
| 08/07/2008 | WO2008094909A2 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions |
| 08/07/2008 | WO2008094896A1 N-substituted tricyclic 3-aminopyrazoles as anti-mitotic tubulin polymerization inhibitors |
| 08/07/2008 | WO2008094869A1 Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders |
| 08/07/2008 | WO2008094866A1 Methods and compositions for transermal delivery of nucleotides |
| 08/07/2008 | WO2008094860A2 Treating ocular diseases using peroxisome proliferator-activated receptor delta antagonists |
| 08/07/2008 | WO2008094825A2 Compositions and methods for maintaining, strengthening, improving or promoting eye health |
| 08/07/2008 | WO2008094737A2 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases |
| 08/07/2008 | WO2008094665A1 Method of treating amyloidosis mediated diseases |
| 08/07/2008 | WO2008094664A1 Methods and compositions for the treatment of pain |
| 08/07/2008 | WO2008094657A1 Compositions and methods of use of phorbol esters |
| 08/07/2008 | WO2008094617A2 Crystalline forms of deferasirox |
| 08/07/2008 | WO2008094602A2 1-h-pyrazolo (3,4b) pyrimidine derivatives and their use as modulators of mitotic kinases |